PSG invests in clinician SaaS platform DoseSpot

PSG managing director Bill Skarinka; principal Chris Andrews; and Chris Collins, vice president, joined DoseSpot’s board, along with Brian Kelly, a senior adviser working with PSG.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this